Atlas Trials

Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

Clinical trial NCT03207243 · COMPLETED

Trial details

NCT number
NCT03207243
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2017-09-14
Primary completion
2019-02-15
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.